Cardlytics Total Assets vs Operating Income Analysis

CDLX Stock

USD 12.58 0.36 2.95%

Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Total Assets and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Total Assets vs Operating Income

Total Assets vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Total Assets account and Operating Income. At this time, the significance of the direction appears to have pay attention.

The correlation between Cardlytics' Total Assets and Operating Income is -0.76. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Operating Income in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Total Assets and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Cardlytics are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Total Assets i.e., Cardlytics' Total Assets and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.76

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Total Assets

Total assets refers to the total amount of Cardlytics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cardlytics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Operating Income

Operating Income is the amount of profit realized from Cardlytics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cardlytics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is likely to rise to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	35.7M	43.7M	29.5M	16.8M
Interest Income	297K	1.4M	3.8M	3.4M

Depreciation And Amortization Interest Income

Cardlytics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.77	0.97	0.96	0.95	0.69	0.32	0.68	0.91	0.11	-0.62	0.16	0.75	0.97	-0.33	-0.19	0.77	0.75	0.86	0.84	-0.54	0.71	0.32	0.82	-0.21	0.87
Short Long Term Debt Total	0.77		0.76	0.73	0.64	0.2	0.52	0.5	0.69	0.46	-0.81	0.07	0.64	0.7	-0.31	-0.06	1.0	0.64	0.85	0.87	-0.63	0.93	0.58	0.82	-0.21	0.76
Other Current Liab	0.97	0.76		0.99	0.9	0.62	0.33	0.55	0.92	0.22	-0.68	0.23	0.63	0.98	-0.36	-0.32	0.76	0.63	0.87	0.84	-0.5	0.71	0.33	0.83	-0.23	0.86
Total Current Liabilities	0.96	0.73	0.99		0.87	0.64	0.27	0.52	0.93	0.21	-0.64	0.35	0.6	0.98	-0.45	-0.41	0.71	0.6	0.82	0.78	-0.39	0.66	0.34	0.79	-0.29	0.81
Total Stockholder Equity	0.95	0.64	0.9	0.87		0.66	0.43	0.77	0.84	-0.08	-0.54	0.0	0.8	0.88	-0.21	-0.06	0.64	0.8	0.85	0.81	-0.58	0.6	0.02	0.79	-0.15	0.91
Other Liab	0.69	0.2	0.62	0.64	0.66		-0.38	0.42	0.62	-0.24	0.05	0.23	0.39	0.76	-0.08	-0.14	0.19	0.39	0.28	0.25	-0.18	0.12	0.25	0.24	0.01	0.34
Net Tangible Assets	0.32	0.52	0.33	0.27	0.43	-0.38		0.42	0.27	0.25	-0.76	-0.35	0.49	0.16	-0.07	0.15	0.54	0.49	0.71	0.71	-0.55	0.62	-0.25	0.72	-0.09	0.7
Property Plant And Equipment Net	0.68	0.5	0.55	0.52	0.77	0.42	0.42		0.43	-0.39	-0.28	-0.23	0.98	0.51	-0.25	0.27	0.49	0.98	0.59	0.58	-0.42	0.47	-0.04	0.52	-0.28	0.69
Current Deferred Revenue	0.91	0.69	0.92	0.93	0.84	0.62	0.27	0.43		0.27	-0.65	0.36	0.5	0.94	-0.44	-0.48	0.69	0.5	0.82	0.77	-0.41	0.63	0.31	0.8	-0.35	0.75
Net Debt	0.11	0.46	0.22	0.21	-0.08	-0.24	0.25	-0.39	0.27		-0.69	0.29	-0.27	0.2	-0.18	-0.44	0.47	-0.27	0.28	0.3	-0.17	0.61	0.56	0.47	-0.03	0.1
Retained Earnings	-0.62	-0.81	-0.68	-0.64	-0.54	0.05	-0.76	-0.28	-0.65	-0.69		-0.04	-0.41	-0.58	0.28	0.24	-0.83	-0.41	-0.85	-0.87	0.57	-0.91	-0.33	-0.94	0.16	-0.75
Accounts Payable	0.16	0.07	0.23	0.35	0.0	0.23	-0.35	-0.23	0.36	0.29	-0.04		-0.24	0.31	-0.75	-0.86	0.0	-0.24	-0.08	-0.1	0.63	-0.03	0.34	0.03	-0.48	-0.19
Cash	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24		0.57	-0.24	0.27	0.64	1.0	0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Non Current Assets Total	0.97	0.7	0.98	0.98	0.88	0.76	0.16	0.51	0.94	0.2	-0.58	0.31	0.57		-0.35	-0.35	0.69	0.57	0.78	0.75	-0.44	0.64	0.39	0.76	-0.19	0.77
Non Currrent Assets Other	-0.33	-0.31	-0.36	-0.45	-0.21	-0.08	-0.07	-0.25	-0.44	-0.18	0.28	-0.75	-0.24	-0.35		0.76	-0.24	-0.24	-0.21	-0.18	-0.44	-0.26	-0.29	-0.3	0.89	-0.13
Other Assets	-0.19	-0.06	-0.32	-0.41	-0.06	-0.14	0.15	0.27	-0.48	-0.44	0.24	-0.86	0.27	-0.35	0.76		-0.01	0.27	-0.07	-0.02	-0.48	-0.07	-0.23	-0.21	0.62	0.04
Long Term Debt	0.77	1.0	0.76	0.71	0.64	0.19	0.54	0.49	0.69	0.47	-0.83	0.0	0.64	0.69	-0.24	-0.01		0.64	0.87	0.89	-0.69	0.93	0.55	0.83	-0.16	0.78
Cash And Short Term Investments	0.75	0.64	0.63	0.6	0.8	0.39	0.49	0.98	0.5	-0.27	-0.41	-0.24	1.0	0.57	-0.24	0.27	0.64		0.7	0.71	-0.53	0.6	0.08	0.62	-0.25	0.78
Net Receivables	0.86	0.85	0.87	0.82	0.85	0.28	0.71	0.59	0.82	0.28	-0.85	-0.08	0.7	0.78	-0.21	-0.07	0.87	0.7		0.99	-0.73	0.83	0.19	0.94	-0.15	0.97
Common Stock Shares Outstanding	0.84	0.87	0.84	0.78	0.81	0.25	0.71	0.58	0.77	0.3	-0.87	-0.1	0.71	0.75	-0.18	-0.02	0.89	0.71	0.99		-0.73	0.85	0.24	0.93	-0.1	0.94
Short Term Investments	-0.54	-0.63	-0.5	-0.39	-0.58	-0.18	-0.55	-0.42	-0.41	-0.17	0.57	0.63	-0.53	-0.44	-0.44	-0.48	-0.69	-0.53	-0.73	-0.73		-0.65	-0.1	-0.63	-0.32	-0.74
Long Term Debt Total	0.71	0.93	0.71	0.66	0.6	0.12	0.62	0.47	0.63	0.61	-0.91	-0.03	0.6	0.64	-0.26	-0.07	0.93	0.6	0.83	0.85	-0.65		0.53	0.9	-0.16	0.74
Non Current Liabilities Total	0.32	0.58	0.33	0.34	0.02	0.25	-0.25	-0.04	0.31	0.56	-0.33	0.34	0.08	0.39	-0.29	-0.23	0.55	0.08	0.19	0.24	-0.1	0.53		0.23	-0.15	0.03
Capital Surpluse	0.82	0.82	0.83	0.79	0.79	0.24	0.72	0.52	0.8	0.47	-0.94	0.03	0.62	0.76	-0.3	-0.21	0.83	0.62	0.94	0.93	-0.63	0.9	0.23		-0.18	0.89
Inventory	-0.21	-0.21	-0.23	-0.29	-0.15	0.01	-0.09	-0.28	-0.35	-0.03	0.16	-0.48	-0.25	-0.19	0.89	0.62	-0.16	-0.25	-0.15	-0.1	-0.32	-0.16	-0.15	-0.18		-0.1
Other Current Assets	0.87	0.76	0.86	0.81	0.91	0.34	0.7	0.69	0.75	0.1	-0.75	-0.19	0.78	0.77	-0.13	0.04	0.78	0.78	0.97	0.94	-0.74	0.74	0.03	0.89	-0.1

Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Short Long Term Debt Total	37K	188.1M	197.2M	235.3M	266.1M	138.7M
Other Current Liab	76.0M	74.8M	313.4M	238.5M	162.2M	126.0M
Total Current Liabilities	78.4M	81.3M	327.4M	248.9M	171.1M	135.4M
Total Stockholder Equity	143.3M	157.2M	690.7M	211.6M	134.8M	98.0M
Other Liab	2.6M	679K	54.5M	334K	384.1K	364.9K
Net Tangible Assets	139.1M	150.4M	(190.5M)	158.1M	181.8M	190.9M
Property Plant And Equipment Net	14.3M	24.6M	21.5M	12.5M	10.6M	14.5M
Current Deferred Revenue	1.1M	349K	3.3M	1.8M	2.4M	1.3M
Net Debt	(104.4M)	(105.1M)	(36.2M)	113.4M	174.3M	183.0M
Retained Earnings	(338.6M)	(394.1M)	(522.6M)	(976.6M)	(1.1B)	(1.1B)
Accounts Payable	1.2M	1.4M	4.6M	3.8M	4.4M	3.2M
Cash	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Non Current Assets Total	28.6M	36.9M	905.1M	441.2M	350.2M	226.1M
Non Currrent Assets Other	10.1M	5.6M	2.4M	2.6M	2.7M	2.6M
Other Assets	10.1M	22.6M	2.4M	2.6M	2.3M	2.2M
Long Term Debt	13K	174.0M	184.4M	226.0M	257.6M	130.8M
Cash And Short Term Investments	104.5M	293.2M	233.5M	121.9M	91.8M	116.8M
Net Receivables	85.4M	86.6M	117.2M	120.1M	126.0M	89.2M
Common Stock Shares Outstanding	23.7M	27.2M	32.2M	33.4M	36.5M	26.9M
Long Term Debt Total	13K	174.0M	184.4M	226.0M	260.0M	273.0M
Liabilities And Stockholders Equity	224.3M	422.5M	1.3B	691.2M	574.1M	440.0M
Non Current Liabilities Total	2.6M	184.1M	245.7M	230.7M	268.2M	206.5M
Capital Surpluse	480.6M	551.4M	1.2B	1.2B	1.4B	1.4B
Inventory	129K	110K	95K	80K	72K	68.4K
Other Current Assets	5.8M	5.7M	8.0M	8.0M	6.1M	5.2M
Other Stockholder Equity	480.6M	551.4M	1.2B	1.2B	1.2B	628.4M
Total Liab	81.0M	265.3M	573.1M	479.6M	439.3M	342.0M
Deferred Long Term Liab	8.5M	3.8M	139K	198K	178.2K	169.3K
Property Plant And Equipment Gross	14.3M	24.6M	11.3M	5.9M	43.7M	45.9M
Total Current Assets	195.7M	385.6M	358.7M	250.0M	223.9M	213.8M
Accumulated Other Comprehensive Income	1.3M	(192K)	486K	5.6M	2.5M	1.9M
Short Term Debt	24K	4.7M	6.0M	4.9M	2.1M	3.6M
Intangible Assets	4.2M	6.7M	138.7M	73.4M	59.6M	35.1M
Property Plant Equipment	14.3M	13.9M	21.5M	5.9M	6.8M	12.5M

Pair Trading with Cardlytics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardlytics Stock

0.66

Sea Buyout Trend

Pair Corr

Moving against Cardlytics Stock

0.78	EVC	Entravision Communications Financial Report 2nd of May 2024	Pair Corr
0.77	WMG	Warner Music Group Financial Report 14th of May 2024	Pair Corr
0.74	IAS	Integral Ad Science Financial Report 2nd of May 2024	Pair Corr
0.7	ADD	Color Star Technology	Pair Corr
0.7	MANU	Manchester United Financial Report 25th of June 2024	Pair Corr

The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.

The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:

How To Invest In Cardlytics

Details

Is Cardlytics Stock a good investment?

Details

What is Cardlytics' Net Worth?

Details

Largest Advertising Companies

View

Largest Media & Entertainment Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Commodity Directory Find actively traded commodities issued by global exchanges

Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.57)

Earnings Share

(3.69)

Revenue Per Share

8.474

Quarterly Revenue Growth

0.081

Return On Assets

(0.06)

The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardlytics Total Assets vs Operating Income Analysis

Total Assets vs Operating Income

Total Assets vs Operating Income Correlation Analysis

Correlation Coefficient

Total Assets

Operating Income

Cardlytics fundamental ratios Correlations

Cardlytics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardlytics fundamental ratios Accounts

Pair Trading with Cardlytics

Moving together with Cardlytics Stock

Moving against Cardlytics Stock

Complementary Tools for Cardlytics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Common Stock Shares Outstanding	+ 0.99	Net Receivables
Non Current Assets Total	+ 0.98	Other Current Liab
Non Current Assets Total	+ 0.98	Total Current Liabilities

Capital Surpluse	- 0.94	Retained Earnings
Long Term Debt Total	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.87	Retained Earnings
Other Assets	- 0.86	Accounts Payable
Net Receivables	- 0.85	Retained Earnings
Long Term Debt	- 0.83	Retained Earnings